{"id":451,"date":"2005-07-20T11:25:00","date_gmt":"2005-07-20T11:25:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=nolato-medical-tecknar-outsourcingavtal-med-novo-nordisk-nyanstaller-20-personer-i-lomma"},"modified":"2005-07-20T11:25:00","modified_gmt":"2005-07-20T11:25:00","slug":"nolato-medical-tecknar-outsourcingavtal-med-novo-nordisk-nyanstaller-20-personer-i-lomma","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/sv\/mfn_news\/nolato-medical-tecknar-outsourcingavtal-med-novo-nordisk-nyanstaller-20-personer-i-lomma\/","title":{"rendered":"Nolato Medical tecknar outsourcingavtal med Novo Nordisk. Nyanst\u00e4ller 20 personer i Lomma"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<pre><p>Nolato Medical, som \u00e4r ett aff\u00e4rsomr\u00e5de i den b\u00f6rsnoterade Nolatokoncernen, har tecknat avtal med det danska l\u00e4kemedelsf\u00f6retaget Novo Nordisk g\u00e4llande produktion av insulinpennan InnoLet. Denna \u00e4r speciellt utvecklad f\u00f6r insulin\u00adpatienter med begr\u00e4nsad fingerr\u00f6rlighet eller nedsatt synf\u00f6rm\u00e5ga.\n\n \u2013 Vi \u00e4r mycket glada \u00f6ver det h\u00e4r outsourcingavtalet med Novo Nordisk, kommenterar Peter Krikstr\u00f6m, som \u00e4r chef f\u00f6r Nolato Medical. Vi har l\u00e4nge samarbetat med Novo Nordisk och f\u00e5r nu en strategiskt viktig bekr\u00e4ftelse p\u00e5 att v\u00e5r m\u00e5linriktade satsning p\u00e5 kapacitet, kompetens och kvalitet har varit riktig.\n\nProduktionen av insulinpennan inleds under h\u00f6sten 2005. Nyrekrytering kommer att g\u00f6ras med cirka 20 personer vid produktionsenheten i Lomma. Outsourcingavtalet inneb\u00e4r en oms\u00e4ttningstillv\u00e4xt p\u00e5 omkring 15 procent f\u00f6r Nolato Medical.<\/p><\/pre>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nolato Medical, som \u00e4r ett aff\u00e4rsomr\u00e5de i den b\u00f6rsnoterade Nolatokoncernen, har tecknat avtal med det danska l\u00e4kemedelsf\u00f6retaget Novo Nordisk g\u00e4llande produktion av insulinpennan InnoLet. Denna \u00e4r speciellt utvecklad f\u00f6r insulin\u00adpatienter med begr\u00e4nsad fingerr\u00f6rlighet eller nedsatt synf\u00f6rm\u00e5ga. \u2013 Vi \u00e4r mycket glada \u00f6ver det h\u00e4r outsourcingavtalet med Novo Nordisk, kommenterar Peter Krikstr\u00f6m, som \u00e4r chef f\u00f6r&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/sv\/mfn_news\/nolato-medical-tecknar-outsourcingavtal-med-novo-nordisk-nyanstaller-20-personer-i-lomma\/\">Continue reading <span class=\"screen-reader-text\">Nolato Medical tecknar outsourcingavtal med Novo Nordisk. Nyanst\u00e4ller 20 personer i Lomma<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-451","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-lang-sv","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"sv","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/mfn_news\/451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/media?parent=451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}